Association between metabolic status and nivolumab efficacy in metastatic non-small cell lung cancer: Focus on resting energy expenditure
Journal of Oncology Pharmacy Practice
Published online on November 03, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
Objective:Non-small cell lung cancer (NSCLC) is a common and deadly cancer, and predicting survival can be useful for guiding treatment. This study aimed to investigate the impact of metabolic status—specifically resting energy expenditure (REE)—and ...
Objective:Non-small cell lung cancer (NSCLC) is a common and deadly cancer, and predicting survival can be useful for guiding treatment. This study aimed to investigate the impact of metabolic status—specifically resting energy expenditure (REE)—and ...